Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.90
Bid: 55.00
Ask: 56.80
Change: 0.00 (0.00%)
Spread: 1.80 (3.273%)
Open: 55.90
High: 55.90
Low: 55.90
Prev. Close: 55.90
GCL Live PriceLast checked at -
Geiger Counter is an Investment Trust

To deliver attractive returns to shareholders principally in the form of capital growth, through investment in companies involved in the exploration, development and production of uranium to supply the nuclear power industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly factsheet December 2023

24 Jan 2024 10:15

RNS Number : 7747A
Geiger Counter Ltd
24 January 2024
 

 

 

Geiger Counter Limited Plc 

 

Monthly Investor Report - December 

 

The full monthly factsheet is now available on the Company's website and a summary can be found below. 

 

NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd

 

Enquiries: 

? 

For the Investment Manager 

CQS (UK) LLP 

Craig Cleland 

0207 201 5368 

For the Company Secretary and Administrator 

BNP Paribas S.A., Jersey Branch 

Dean Plowman/Ann-Marie Pereira 

01534 813 967/ 01534 709198 

 

----------------------------------------------------------------------- 

 

Fund Description 

 

The objective of the Geiger Counter Fund is to provide investors with the potential for capital growth through investment primarily in the securities of companies involved in the exploration, development and production of energy, predominantly within the uranium industry. Up to 30% of the value of the Company's investment portfolio may be invested in other resource-related companies from outside the energy sector.

 

Portfolio Managers 

 

Keith Watson and Robert Crayfourd 

 

 

Key Advantages for the Investor 

· Access to mining assets in the uranium sector

· May benefit from embedded subscription share

· Low correlation to major asset classes

 

 

Key Fund Facts1 

 

 

Total Gross Assets 

£100.4m 

Reference Currency 

GBP 

Ordinary Shares: 

Net Asset Value 

67.07p 

Mid-Market Price  

54.00p 

Net gearing 

14.31% 

Discount 

(19.49%) 

 

 

Ordinary Share and NAV Performance2 

 

 

One Month 

Three Months 

One Year 

Three Years 

Five Years 

 

(%) 

(%) 

(%) 

(%) 

(%) 

NAV 

1.21 

2.44 

44.02 

169.03

270.35 

Share Price 

0.93 

3.85 

26.32

100.00 

164.71 

 

 

Commentary3 

 

The spot U3O8 price ended December at $91.50/lb, up 13.3% over the month.

Symbolic of its ever more influential role in electricity generation, nuclear power received

widespread endorsement from the COP 28 conference with an international agreement to triple installed generating capacity by 2050. This boosted uranium price momentum into the calendar

year-end.

 

The passing of a US House vote to restrict the importation of Russian-sourced material saw the bill progress through to the Senate for consideration, potentially adding impetus to fuel prices. However, equities did not keep pace with the uranium price rise with the Fund NAV gaining 1.2% in December, similar to the Solactive Uranium Pure Play Index sterling return.

 

During the month, Nexgen announced that it had received its provincial environmental permits, the first company in more than 20 years to receive full provincial EA approval for a uranium project in Saskatchewan. With all necessary First Nations benefits agreements already in place, we believe the development of the project has de-risked considerably. The issue of Federal permits, which includes an official assessment of the Environmental Impact Assessment by the Canadian Nuclear Safety Commission, and which is expected to be issued later this year, represents the final step required for the project's development. Permitting progress helped lift the Nexgen share price by over 5% in sterling terms over the month. Fission Energy, which owns the neighbouring Patterson Lake project, rose by nearly 9% in sterling terms over the month.

 

Physically backed vehicles such as the Sprott Uranium Trust and Yellow Cake also struggled to keep pace with the uranium price rise, although both registered sterling returns of over 10% during December. The Sprott Trust share price briefly exceeded its NAV allowing it to purchase a modest 256k lbs of U3O8 during the month. The main detractors to Fund performance were Cameco and Ur-Energy, whose share prices slipped over 6.7% and 5.0% respectively in sterling terms during December.

 

 

 

Gross Leverage

(%)

Commitment Leverage

(%)

Geiger Counter Ltd 

115

115

 

 

CQS (UK) LLP

4th Floor, One Strand, London WC2N 5HR, United Kingdom

T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200

 

CQS (US), LLC

152 West 57th Street, 40th Floor, New York, NY 10019, US

T: +1 212 259 2900 | F: +1 212 259 2699

 

CQS (Hong Kong) Limited

3305 AIA Tower, 183 Electric Road, North Point, Hong Kong, China

T: +852 3920 8600 | F: +852 2521 3189

 

Tavistock Communications

18 St. Swithin's Lane, London EC4N 8AD

T: +44 20 7920 3150 | geigercounter@tavistock.co.uk

 

Sources: 1R&H Fund Services (Jersey) Limited, as at the last business day of the month indicated at the top of this report. 2R&H Fund Services Limited/DataStream, as at the last business day of the month indicated at the top of this report, total return performance net of fees and expenses based on bid prices. These include historic returns and past performance is not a reliable indicator of future results. The value of investments can go down as well as up. Please read the important legal notice at the end of this document. 3Market data sourced from Bloomberg unless otherwise stated. The Fund may since have exited some or all of the positions detailed in the commentary.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCEANFLASALEEA
Date   Source Headline
3rd May 20242:20 pmRNSNet Asset Value(s)
2nd May 20242:45 pmRNSNet Asset Value(s)
1st May 20243:35 pmRNSNet Asset Value(s)
30th Apr 20243:30 pmRNSNet Asset Value(s)
30th Apr 20242:00 pmRNSShare Buyback
29th Apr 202412:45 pmRNSNet Asset Value(s)
29th Apr 202412:30 pmRNSShare Buyback
26th Apr 20242:15 pmRNSGCL MONTHLY FACT SHEET MARCH 2024
26th Apr 202412:15 pmRNSNet Asset Value(s)
26th Apr 202412:00 pmRNSShare Buyback
25th Apr 20242:45 pmRNSNet Asset Value(s)
25th Apr 20242:00 pmRNSShare Buyback
24th Apr 20242:40 pmRNSNet Asset Value(s)
24th Apr 20241:30 pmRNSShare Buyback
23rd Apr 20243:30 pmRNSNet Asset Value(s)
23rd Apr 20241:45 pmRNSShare Buyback
22nd Apr 20243:35 pmRNSNet Asset Value(s)
22nd Apr 20241:30 pmRNSShare Buyback
19th Apr 20242:35 pmRNSNet Asset Value(s)
18th Apr 20241:35 pmRNSNet Asset Value(s)
17th Apr 202412:20 pmRNSNet Asset Value(s)
16th Apr 20245:20 pmRNSNet Asset Value(s)
15th Apr 202412:50 pmRNSNet Asset Value(s)
12th Apr 20241:35 pmRNSNet Asset Value(s)
11th Apr 20241:15 pmRNSNet Asset Value(s)
10th Apr 20243:40 pmRNSNet Asset Value(s)
9th Apr 20241:25 pmRNSNet Asset Value(s)
8th Apr 20241:10 pmRNSNet Asset Value(s)
5th Apr 20242:05 pmRNSNet Asset Value(s)
4th Apr 20241:10 pmRNSNet Asset Value(s)
3rd Apr 20242:40 pmRNSNet Asset Value(s)
3rd Apr 20249:00 amRNSInvestment Manager Acquisition
2nd Apr 20243:50 pmRNSNet Asset Value(s)
28th Mar 20241:50 pmRNSNet Asset Value(s)
27th Mar 20241:00 pmRNSNet Asset Value(s)
27th Mar 20249:33 amRNSNotification to Shareholders - Subscription Rights
26th Mar 20242:55 pmRNSNet Asset Value(s)
25th Mar 20241:00 pmRNSNet Asset Value(s)
22nd Mar 20244:45 pmRNSPotential listing on the London Stock Exchange
22nd Mar 20241:15 pmRNSNet Asset Value(s)
21st Mar 20241:25 pmRNSNet Asset Value(s)
20th Mar 20242:30 pmRNSNet Asset Value(s)
19th Mar 20244:45 pmRNSNet Asset Value(s)
18th Mar 20241:45 pmRNSNet Asset Value(s)
15th Mar 202411:35 amRNSNet Asset Value(s)
14th Mar 202412:45 pmRNSNet Asset Value(s)
13th Mar 20242:15 pmRNSNet Asset Value(s)
12th Mar 20245:00 pmRNSAGM Statement - Results of AGM 2024
12th Mar 20241:00 pmRNSNet Asset Value(s)
11th Mar 20241:35 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.